Home » Topics » Regulatory » Patents

Patents
RSS

Series of Na+/Ca2+ exchange inhibitors for ischemic disorders from Taisho

Jan. 7, 1999

Another series of heterocyclic thrombin inhibitors revealed by Lilly

Jan. 5, 1999

Novel compounds synthesized at BMS particularly useful for prevention of postsurgical adhesions

Jan. 5, 1999

Warner-Lambert claims new kappa-opioid agonists and their use

Jan. 4, 1999

Lilly's new 5-HT1D agonists claimed for CNS and bladder disorders

Jan. 4, 1999

New COX-2 inhibitor series patented by Searle

Jan. 4, 1999

Thrombin inhibitors in development at Lilly

Jan. 4, 1999

Novel compounds synthesized at SmithKline Beecham act at several 5-HT receptor subtypes

Jan. 4, 1999

Development of new beta-lactamase inhibitors revealed by Japanese laboratories

Dec. 30, 1998

Cytokine production inhibitors for inflammatory disorders in development at Ortho-McNeil

Dec. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
XPC-837 restores network dysfunction in Dravet syndrome models
BioWorld Science
Researchers from Xenon Pharmaceuticals Inc. described the preclinical efficacy of XPC-837 in models of Dravet syndrome, a severe developmental and epileptic...